Take Solutions touches roof on entering into longevity and Anti-ageing market in India
Take Solutions is currently trading at upper limit of Rs. 48.91, up by 0.95 points or 1.98% from its previous closing of Rs. 47.96 on the BSE.
The scrip opened at Rs. 48.91 and has touched a high and low of Rs. 48.91 and Rs. 48.85 respectively. So far 28212 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 49.90 on 13-Feb-2026 and a 52 week low of Rs. 7.30 on 12-May-2025.
Last one week high and low of the scrip stood at Rs. 48.91 and Rs. 46.37 respectively. The current market cap of the company is Rs. 723.55 crore.
The Institutions and Non-Institutions held 0.56% and 99.44% stake in the company respectively.
Take Solutions has entered into the rapidly expanding longevity and Anti-ageing market in India. The initiative is designed to leverage the company’s established expertise in clinical research, life sciences, and regulatory processes to build a scalable platform across consumer health products and digital wellness solutions.
Take Solutions’ entry strategy is centered on a dual model that combines product innovation with technology-enabled health solutions. The company plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools that can help consumers track and optimize metabolic health, sleep, cognition, and biological aging. This approach is intended to create a differentiated offering in a market that is still underpenetrated but increasingly attractive to investors due to its repeat-purchase potential and margin profile.
